mRNA vaccines: A matter of delivery.
作者信息
Cao Yuhong, Gao George F
机构信息
CAS Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Chinese Academy of Sciences, Beijing 100190, China.
CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
出版信息
EClinicalMedicine. 2021 Feb 3;32:100746. doi: 10.1016/j.eclinm.2021.100746. eCollection 2021 Feb.
Abstract
摘要
相似文献
1
mRNA vaccines: A matter of delivery.信使核糖核酸疫苗：递送问题
EClinicalMedicine. 2021 Feb 3;32:100746. doi: 10.1016/j.eclinm.2021.100746. eCollection 2021 Feb.
2
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.核酸疫苗：非病毒 mRNA 疫苗传递的前景。
Expert Opin Drug Deliv. 2014 Jun;11(6):885-99. doi: 10.1517/17425247.2014.901308. Epub 2014 Mar 26.
3
Self-amplifying mRNA vaccines.自我扩增mRNA疫苗。
Adv Genet. 2015;89:179-233. doi: 10.1016/bs.adgen.2014.10.005. Epub 2014 Dec 4.
4
mRNA vaccine delivery using lipid nanoparticles.使用脂质纳米颗粒递送信使核糖核酸疫苗
Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006.
5
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ.通过原位电穿孔增强自我扩增mRNA疫苗的递送和效力。
Vaccines (Basel). 2013 Aug 22;1(3):367-83. doi: 10.3390/vaccines1030367.
6
Engineering intranasal mRNA vaccines to enhance lymph node trafficking and immune responses.设计鼻内mRNA疫苗以增强淋巴结转运和免疫反应。
Acta Biomater. 2017 Dec;64:237-248. doi: 10.1016/j.actbio.2017.10.019. Epub 2017 Oct 10.
7
Mechanism of action of mRNA-based vaccines.mRNA 疫苗的作用机制。
Expert Rev Vaccines. 2017 Sep;16(9):871-881. doi: 10.1080/14760584.2017.1355245. Epub 2017 Jul 28.
8
The European Regulatory Environment of RNA-Based Vaccines.基于RNA的疫苗的欧洲监管环境。
Methods Mol Biol. 2017;1499:203-222. doi: 10.1007/978-1-4939-6481-9_13.
9
mRNA Cancer Vaccines-Messages that Prevail.mRNA 癌症疫苗——占主导地位的信息。
Curr Top Microbiol Immunol. 2017;405:145-164. doi: 10.1007/82_2017_509.
10
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.mRNA 作为一种变革性技术，用于开发疫苗以控制传染病。
Mol Ther. 2019 Apr 10;27(4):757-772. doi: 10.1016/j.ymthe.2019.01.020. Epub 2019 Feb 7.
引用本文的文献
1
A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants.一种含有 S-RBD 和 HA 的嵌合 mRNA 疫苗，可提供针对流感和 COVID-19 变体的广泛保护。
PLoS Pathog. 2024 Sep 20;20(9):e1012508. doi: 10.1371/journal.ppat.1012508. eCollection 2024 Sep.
2
Novel Endogenous Engineering Platform for Robust Loading and Delivery of Functional mRNA by Extracellular Vesicles.新型内源性工程化平台，通过细胞外囊泡实现功能性 mRNA 的稳健加载和递送。
Adv Sci (Weinh). 2024 Nov;11(42):e2407619. doi: 10.1002/advs.202407619. Epub 2024 Sep 9.
3
Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?针对肿瘤相关血管生成的核酸癌症疫苗。mRNA 疫苗能否带来改变游戏规则的效果？
Front Immunol. 2024 Jul 16;15:1433185. doi: 10.3389/fimmu.2024.1433185. eCollection 2024.
4
Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging.体内成像揭示小鼠和非人灵长类动物中mRNA脂质纳米颗粒的不同动态。
NPJ Vaccines. 2024 Jun 20;9(1):113. doi: 10.1038/s41541-024-00900-5.
5
Broad-spectrum Delta-BA.2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex.广谱 Delta-BA.2 串联融合异源二聚体 mRNA 疫苗，采用脂质多聚物递送。
PLoS Pathog. 2024 Apr 1;20(4):e1012116. doi: 10.1371/journal.ppat.1012116. eCollection 2024 Apr.
6
Hybrid Lipid Nanocapsules: A Robust Platform for mRNA Delivery.杂交脂质纳米胶囊：mRNA 传递的强大平台。
ACS Appl Mater Interfaces. 2024 Apr 3;16(13):15981-15992. doi: 10.1021/acsami.4c00992. Epub 2024 Mar 20.
7
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults.mRNA 编码 RSV 疫苗在健康老年人中进行的 1 期临床试验中包含 12 个月的加强针的安全性和免疫原性。
J Infect Dis. 2024 Sep 23;230(3):e647-e656. doi: 10.1093/infdis/jiae081.
8
Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial.mRNA 呼吸道合胞病毒疫苗在健康年轻成年人中进行的 1 期临床试验的安全性、耐受性和免疫原性。
J Infect Dis. 2024 Sep 23;230(3):e637-e646. doi: 10.1093/infdis/jiae035.
9
Future Prospects, Approaches, and the Government's Role in the Development of a Hepatitis C Virus Vaccine.丙型肝炎病毒疫苗研发的未来前景、方法及政府作用
Pathogens. 2023 Dec 31;13(1):38. doi: 10.3390/pathogens13010038.
10
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria.基于反向疫苗学的下一代疫苗开发相对于传统疫苗在对抗抗生素耐药细菌方面的巨大潜力。
Vaccines (Basel). 2023 Jul 20;11(7):1264. doi: 10.3390/vaccines11071264.
本文引用的文献
1
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
2
mRNA vaccines - a new era in vaccinology.mRNA 疫苗——疫苗学的新纪元。
Nat Rev Drug Discov. 2018 Apr;17(4):261-279. doi: 10.1038/nrd.2017.243. Epub 2018 Jan 12.
3
Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.Toll样受体对RNA识别的抑制作用：核苷修饰的影响及RNA的进化起源
Immunity. 2005 Aug;23(2):165-75. doi: 10.1016/j.immuni.2005.06.008.
4
Direct gene transfer into mouse muscle in vivo.将基因直接导入活体小鼠肌肉。
Science. 1990 Mar 23;247(4949 Pt 1):1465-8. doi: 10.1126/science.1690918.
Zotero 插件